QOP
RLAY icon

Quinn Opportunity Partners’s Relay Therapeutics RLAY Stock Holding History

Quinn Opportunity Partners’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30,000
Closed -$157K – 404
2025
Q3 		$157K Buy
30,000
+20,000
+200% +$76.3K 0.01% 288
2025
Q2 		$34.6K Buy
+10,000
New +$29.7K ﹤0.01% 345

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quinn Opportunity Partners's RLAY Position: Q4 2025 in Review

Quinn Opportunity Partners sold out of Relay Therapeutics (RLAY) in Q4 2025, closing a stake of 30,000 shares — an estimated $157K sold.

Quinn Opportunity Partners first reported a position in RLAY in Q2 2025 and held it in 2 quarters. The position peaked at $157K in Q3 2025. 227 funds tracked by Wall St. Rank hold RLAY as of Q4 2025.

  • Quinn Opportunity Partners reported no remaining Relay Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Quinn Opportunity Partners sold 30,000 Relay Therapeutics shares in Q4 2025, an estimated $157K.
  • Quinn Opportunity Partners first reported a position in Relay Therapeutics in Q2 2025 and held it in 2 quarters.
  • Quinn Opportunity Partners's Relay Therapeutics position peaked at $157K in Q3 2025.
  • 227 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2025.

Based on Quinn Opportunity Partners's 13F filing for Q4 2025, filed 13 Feb 2026.